tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:9966 Stock Latest News

Alphamab Oncology Initiates HK$30 Million Share Repurchase Plan
Company AnnouncementsAlphamab Oncology Initiates HK$30 Million Share Repurchase Plan
21d ago
9966
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
1M ago
9966
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
1M ago
9966
Alphamab Oncology Grants Award Shares to Key Personnel
PremiumCompany Announcements
Alphamab Oncology Grants Award Shares to Key Personnel
1M ago
9966
Alphamab Oncology’s JSKN003 Receives Breakthrough Therapy Designation for HER2+ CRC
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Receives Breakthrough Therapy Designation for HER2+ CRC
1M ago
9966
Alphamab Oncology’s JSKN003 Shows Promising Results in Cancer Treatment Trials
PremiumCompany AnnouncementsAlphamab Oncology’s JSKN003 Shows Promising Results in Cancer Treatment Trials
1M ago
9966
Alphamab Oncology Reports Promising Phase III Trial Results for KN026
Premium
Company Announcements
Alphamab Oncology Reports Promising Phase III Trial Results for KN026
1M ago
9966
Alphamab Oncology Provides Additional Details on 2024 Annual Report
Premium
Company Announcements
Alphamab Oncology Provides Additional Details on 2024 Annual Report
2M ago
9966
Alphamab Oncology Announces HK$20 Million Share Repurchase Plan
PremiumCompany Announcements
Alphamab Oncology Announces HK$20 Million Share Repurchase Plan
2M ago
9966
Alphamab Oncology Addresses Non-Compliance in Director’s Share Dealings
PremiumCompany Announcements
Alphamab Oncology Addresses Non-Compliance in Director’s Share Dealings
2M ago
9966
Alphamab Oncology’s KN026 Gains NMPA Acceptance for HER2+ Gastric Cancer Treatment
PremiumCompany Announcements
Alphamab Oncology’s KN026 Gains NMPA Acceptance for HER2+ Gastric Cancer Treatment
3M ago
9966
Alphamab Oncology Reports Strong Interim Results and Clinical Progress
PremiumCompany Announcements
Alphamab Oncology Reports Strong Interim Results and Clinical Progress
3M ago
9966
Alphamab Oncology Announces Technology Development Collaboration with Suzhou Alphamab
PremiumCompany AnnouncementsAlphamab Oncology Announces Technology Development Collaboration with Suzhou Alphamab
3M ago
9966
Alphamab Oncology Announces Positive Profit Turnaround for H1 2025
Premium
Company Announcements
Alphamab Oncology Announces Positive Profit Turnaround for H1 2025
4M ago
9966
Alphamab Oncology Schedules Board Meeting to Review Interim Results
Premium
Company Announcements
Alphamab Oncology Schedules Board Meeting to Review Interim Results
4M ago
9966
Alphamab Oncology Partners with Suzhou Alphamab for ADC Development
PremiumCompany Announcements
Alphamab Oncology Partners with Suzhou Alphamab for ADC Development
4M ago
9966
Alphamab Oncology’s JSKN022 IND Application Accepted by CDE
PremiumCompany Announcements
Alphamab Oncology’s JSKN022 IND Application Accepted by CDE
4M ago
9966
Alphamab Oncology’s JSKN003 Gains U.S. FDA Approval for Phase II Study
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Gains U.S. FDA Approval for Phase II Study
4M ago
9966
Alphamab’s JSKN003 Receives Orphan Drug Designation from U.S. FDA
PremiumCompany Announcements
Alphamab’s JSKN003 Receives Orphan Drug Designation from U.S. FDA
4M ago
9966
Alphamab Oncology Directors Boost Shareholding, CEO Exercises Options
PremiumCompany AnnouncementsAlphamab Oncology Directors Boost Shareholding, CEO Exercises Options
4M ago
9966
Alphamab Oncology Forms Nomination Committee to Strengthen Governance
Premium
Company Announcements
Alphamab Oncology Forms Nomination Committee to Strengthen Governance
5M ago
9966
Alphamab Oncology Announces Board Changes
Premium
Company Announcements
Alphamab Oncology Announces Board Changes
5M ago
9966

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >